<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651517</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-LUNG-01-2020</org_study_id>
    <nct_id>NCT04651517</nct_id>
  </id_info>
  <brief_title>Pilot Study of the ACE System in Lung Procedures</brief_title>
  <official_title>Pilot Study of the XACT Robotics ACE System for Image Guided Percutaneous Procedures in the Lung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xact Robotics Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xact Robotics Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the XACT ACE Robotic System in lung procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The XACT ACE Robotic System is a user-controlled positioning system intended to assist in the&#xD;
      planning and advancement of an instrument during Computed Tomography (CT) guided percutaneous&#xD;
      lung procedures. The system is used for trajectory planning and is intended to assist the&#xD;
      physician in the positioning of an instrument, such as a needle, where CT imaging is used for&#xD;
      target trajectory planning and intraoperative tracking. This study will evaluate safety and&#xD;
      accuracy of the XACT ACE Robotic System in subjects undergoing CT guided, minimally invasive&#xD;
      percutaneous procedures of the lung in the interventional radiology suite.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Actual">August 3, 2021</completion_date>
  <primary_completion_date type="Actual">August 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Subjects 18 years of age or older who are undergoing CT guided, minimally invasive percutaneous procedures of the lung.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence, severity, and frequency of adverse events and device-related adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Performance Evaluation - Clinical Accuracy</measure>
    <time_frame>1 hour</time_frame>
    <description>Percent of procedures in which the needle reached the pre-defined target based on the physician's determination and CT imaging confirmation (clinical accuracy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Performance Evaluation - System Accuracy</measure>
    <time_frame>1 hour</time_frame>
    <description>The measured distance from the tip of the needle/tool to the target location at the end of the needle/tip insertion.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Study arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects undergoing procedures with the XACT ACE Robotic system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>XACT ACE Robotics study arm</intervention_name>
    <description>Subjects will undergo lung procedures with the physician utilizing the XACT ACE Robotic System.</description>
    <arm_group_label>Study arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age&#xD;
&#xD;
          2. Subjects undergoing CT-guided, minimally invasive percutaneous lung procedures in the&#xD;
             interventional radiology suite, e.g., core biopsy, fine needle aspiration (FNA), tumor&#xD;
             ablation, etc.&#xD;
&#xD;
          3. Following planning and registration CT scans, subject is found eligible to undergo&#xD;
             CT-guided, minimally invasive percutaneous procedure&#xD;
&#xD;
          4. Subject is willing to sign informed consent&#xD;
&#xD;
          5. Subject is capable of adhering to study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects in whom the target is within 1 cm of a major blood vessel, major nerve or&#xD;
             heart&#xD;
&#xD;
          2. Subject with significant coagulopathy&#xD;
&#xD;
          3. Subject with preexisting or unstable medical condition(s), which in the opinion of the&#xD;
             investigator, might interfere with the conduct of the study&#xD;
&#xD;
          4. Subjects who are pregnant or nursing&#xD;
&#xD;
          5. Following planning and registration CT scans, required clinical trajectory to target&#xD;
             is beyond system workspace limits (e.g., entry angle is too sharp)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Flacke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lahey Hospital &amp; Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

